Want to see CH:BSLN full AI Analyst Report?
Basilea Pharmaceutica (BSLN) Q2 2024 Earnings Report
CH:BSLN Q2 2024 EPS Results
- Actual EPS
- CHF 1.58
- Consensus EPS
- CHF 1.17
- Beat/Miss
- Beat by +CHF 0.41
- One Year Ago EPS
- CHF 2.43
CH:BSLN Q2 2024 Revenue Results
- Actual Revenue
- CHF 76.29M
- Expected Revenue
- CHF 106.10M
- Beat/Miss
- Missed by -CHF 29.81M
- YoY Revenue Growth
- -10.14%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/13/2024
- Time
- Before Open
- Conference Call
- Tuesday, August 13, 2024
CH:BSLN Upcoming Earnings
Basilea Pharmaceutica's next earnings date is estimated for February 16, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:BSLN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 16, 2027 | 2026 (Q4) | 2.88- | 1.99 | ― | ― |
| Aug 18, 2026 | 2026 (Q2) | 3.342.13 | 1.26 | 69.05% (+0.87) | |
| Feb 17, 2026 | 2025 (Q4) | 1.641.99 | 4.7 | -57.70% (-2.71) | |
| Aug 19, 2025 | 2025 (Q2) | 2.031.26 | 1.57 | -20.00% (-0.32) | |
| Feb 18, 2025 | 2024 (Q4) | 3.244.70 | -1.71 | 375.66% (+6.41) | |
| Aug 13, 2024 | 2024 (Q2) | 1.171.57 | 2.43 | -35.21% (-0.86) | |
| Feb 13, 2024 | 2023 (Q4) | -2.02-1.71 | 2.05 | -183.17% (-3.75) | |
| Aug 15, 2023 | 2023 (Q2) | 0.812.43 | -1.03 | 336.02% (+3.46) | |
| Feb 14, 2023 | 2022 (Q4) | -1.302.05 | 1.26 | 62.70% (+0.79) | |
| Aug 16, 2022 | 2022 (Q2) | -1.28-1.03 | -1.84 | 44.02% (+0.81) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
